SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2021-04-23 13:14
Tx date 2021-04-23
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Common Shares Class A
10 - Acquisition or disposition in the public market
$5,471
+4,800 vol
$1.14 each
143,000
Filed 2021-04-23 07:03
Tx date 2021-04-22
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$6,000
+12,500 vol
$0.48 each
242,500
Filed 2021-04-22 06:24
Tx date 2021-04-21
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Common Shares Class A
10 - Acquisition or disposition in the public market
$10,710
+10,200 vol
$1.05 each
138,200
Filed 2020-12-04 12:49
Tx date 2020-12-02
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Warrants
11 - Acquisition or disposition carried out privately

+30,000 vol
130,000
Filed 2020-12-04 12:43
Tx date 2020-12-02
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Non-Convertible, Secured, 10%, 3 Years
11 - Acquisition or disposition carried out privately
$
+$60 vol
$1,000 each
$60
Filed 2020-12-04 12:41
Tx date 2018-09-18
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Non-Convertible, Secured, 10%, 3 Years
00 - Opening Balance-Initial SEDI Report
Filed 2020-10-19 16:19
Tx date 2020-10-19
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$600.00
+1,000 vol
$0.60 each
906,000
Filed 2020-09-14 11:19
Tx date 2020-09-10
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants VPH.WT. A.(10SEP2022 Warrants)
15 - Acquisition or disposition under a prospectus

+12,500 vol
12,500
Filed 2020-09-14 11:12
Tx date 2018-12-27
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants VPH.WT. A.(10SEP2022 Warrants)
00 - Opening Balance-Initial SEDI Report
Filed 2020-09-14 11:12
Tx date 2020-09-10
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
15 - Acquisition or disposition under a prospectus
$30,000
+25,000 vol
$1.20 each
1,680,555
Filed 2020-08-27 11:36
Tx date 2020-08-21
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Warrants
11 - Acquisition or disposition carried out privately

+100,000 vol
100,000
Filed 2020-08-26 11:16
Tx date 2018-09-18
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-08-26 11:15
Tx date 2020-08-21
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$32,000
+100,000 vol
$0.32 each
230,000
Filed 2020-07-13 15:51
Tx date 2020-07-10
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+82,500 vol
701,000
Filed 2020-07-13 15:49
Tx date 2020-07-10
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Debentures (Non-Convertible) July 2020
16 - Acquisition or disposition under a prospectus exemption

+$55,000 vol
$55,000
Filed 2020-07-13 15:43
Tx date 2018-12-27
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Debentures (Non-Convertible) July 2020
00 - Opening Balance-Initial SEDI Report
Filed 2020-07-01 16:43
Tx date 2020-06-30
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$60,000
+100,000 vol
$0.60 each
1,075,000
Filed 2020-05-25 12:10
Tx date 2020-05-25
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$32,000
+80,000 vol
$0.40 each
1,655,555
Filed 2020-05-19 16:41
Tx date 2020-05-14
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
$2,250
+25,000 vol
$0.09 each
618,500
Filed 2020-05-19 13:19
Tx date 2020-05-14
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
$3,400
+40,000 vol
$0.085 each
593,500
Filed 2020-04-25 07:06
Tx date 2020-04-20
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$1,375
+5,000 vol
$0.275 each
130,000
Filed 2020-04-25 07:05
Tx date 2020-04-20
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$6,250
+25,000 vol
$0.25 each
125,000
Filed 2020-04-23 18:41
Tx date 2020-04-21
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
$122,000
+244,000 vol
$0.50 each
708,000
Filed 2020-04-23 18:20
Tx date 2020-04-21
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
10 - Acquisition or disposition in the public market
$
+$122,000 vol
$0.30 each
$354,000
Filed 2020-04-16 15:28
Tx date 2020-04-16
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$40,000
+200,000 vol
$0.20 each
905,000
Filed 2020-02-19 15:02
Tx date 2020-02-19
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Common Shares Class A
10 - Acquisition or disposition in the public market
$7,440
+16,000 vol
$0.465 each
128,000
Filed 2020-02-19 15:01
Tx date 2020-02-18
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Common Shares Class A
10 - Acquisition or disposition in the public market
$5,580
+12,000 vol
$0.465 each
112,000
Filed 2020-01-06 08:07
Tx date 2019-12-31
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+114,000 vol
464,000
Filed 2020-01-06 08:04
Tx date 2019-12-31
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
16 - Acquisition or disposition under a prospectus exemption
$
+$57,000 vol
$1,000 each
$232,000
Filed 2020-01-02 07:59
Tx date 2019-12-31
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
$95.00
+1,000 vol
$0.095 each
553,500
Filed 2019-12-28 06:55
Tx date 2019-12-24
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$3,820
+8,000 vol
$0.4775 each
1,575,555
Filed 2019-12-26 07:47
Tx date 2019-12-23
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$4,250
+10,000 vol
$0.425 each
1,567,555
Filed 2019-12-20 12:26
Tx date 2019-12-19
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$1,975
+5,000 vol
$0.395 each
1,557,555
Filed 2019-12-16 17:21
Tx date 2019-12-16
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$3,500
+10,000 vol
$0.35 each
1,552,555
Filed 2019-12-13 12:13
Tx date 2019-12-12
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$480.00
+1,500 vol
$0.32 each
1,542,555
Filed 2019-12-13 12:12
Tx date 2019-12-11
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$4,239
+15,000 vol
$0.2826 each
1,541,055
Filed 2019-12-05 17:10
Tx date 2019-12-05
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$2,925
+10,000 vol
$0.2925 each
1,526,055
Filed 2019-12-05 17:09
Tx date 2019-12-04
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$1,450
+5,000 vol
$0.29 each
1,516,055
Filed 2019-12-05 17:08
Tx date 2019-12-05
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,425
+10,000 vol
$0.2425 each
705,000
Filed 2019-12-03 15:32
Tx date 2019-12-02
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
$10,000
+200,000 vol
$0.05 each
452,500
Filed 2019-12-03 15:31
Tx date 2019-12-03
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
$5,000
+100,000 vol
$0.05 each
552,500
Filed 2019-12-02 16:14
Tx date 2019-12-02
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
$10,000
+200,000 vol
$0.05 each
Filed 2019-12-02 16:14
Tx date 2019-12-02
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
$10,000
+200,000 vol
$0.05 each
452,500
Filed 2019-12-02 14:17
Tx date 2019-11-28
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$17,750
+71,000 vol
$0.25 each
1,511,055
Filed 2019-12-02 14:16
Tx date 2019-11-28
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,840
+38,000 vol
$0.18 each
695,000
Filed 2019-10-23 11:11
Tx date 2019-10-08
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
16 - Acquisition or disposition under a prospectus exemption
$
+$175,000 vol
$0.30 each
$175,000
Filed 2019-10-23 11:01
Tx date 2019-10-22
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Common Shares Class A
10 - Acquisition or disposition in the public market
$25,000
+100,000 vol
$0.25 each
100,000
Filed 2019-10-23 08:26
Tx date 2019-10-22
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Common Shares Class A
10 - Acquisition or disposition in the public market
$20,000
+100,000 vol
$0.20 each
100,000
Filed 2019-10-23 08:26
Tx date 2019-10-22
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Common Shares Class A
10 - Acquisition or disposition in the public market
$20,000
+100,000 vol
$0.20 each
Filed 2019-10-23 08:25
Tx date 2018-12-27
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
Filed 2019-10-11 11:55
Tx date 2019-10-08
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
10 - Acquisition or disposition in the public market
$
+$175 vol
$1,000 each
Filed 2019-10-22 17:42
Tx date 2019-10-21
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$4,400
+22,000 vol
$0.20 each
100,000
Filed 2019-10-18 13:49
Tx date 2019-10-16
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$15,600
+78,000 vol
$0.20 each
78,000
Filed 2019-10-18 13:48
Tx date 2018-09-18
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-10-11 12:00
Tx date 2019-10-08
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market

+350,000 vol
350,000
Filed 2019-10-11 11:57
Tx date 2018-09-18
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-10-11 11:55
Tx date 2019-10-08
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
10 - Acquisition or disposition in the public market
$
+$175 vol
$1,000 each
$175
Filed 2019-10-11 11:47
Tx date 2018-09-18
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
00 - Opening Balance-Initial SEDI Report
Filed 2019-10-01 15:41
Tx date 2019-10-01
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$4,024
+11,500 vol
$0.35 each
1,440,055
Filed 2019-09-27 07:42
Tx date 2019-09-26
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$162.50
+500 vol
$0.325 each
657,000
Filed 2019-09-27 07:41
Tx date 2019-09-26
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$312.50
+1,000 vol
$0.3125 each
1,428,555
Filed 2019-09-25 08:51
Tx date 2019-09-19
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
$2,800
+56,000 vol
$0.05 each
252,500
Filed 2019-09-20 08:00
Tx date 2019-09-19
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
$70.00
+1,000 vol
$0.07 each
196,500
Filed 2019-09-18 13:38
Tx date 2019-09-18
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$46,398
+148,000 vol
$0.3135 each
1,427,555
Filed 2019-09-18 13:37
Tx date 2019-09-17
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$3,624
+12,500 vol
$0.29 each
1,279,555
Filed 2019-09-18 13:36
Tx date 2019-09-16
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$11,455
+39,500 vol
$0.29 each
1,267,055
Filed 2019-09-18 13:35
Tx date 2019-09-16
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
$150.00
+1,500 vol
$0.10 each
195,500
Filed 2019-09-12 17:22
Tx date 2019-09-12
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
$3,430
+49,000 vol
$0.07 each
194,000
Filed 2019-09-12 17:21
Tx date 2019-09-12
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
$1,250
+25,000 vol
$0.05 each
145,000
Filed 2019-09-04 07:38
Tx date 2019-09-03
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$290.00
+1,000 vol
$0.29 each
656,500
Filed 2019-09-04 07:37
Tx date 2019-09-03
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,709
+6,000 vol
$0.285 each
655,500
Filed 2019-08-29 16:40
Tx date 2019-08-27
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$6,090
+21,000 vol
$0.29 each
1,227,555
Filed 2019-08-22 11:41
Tx date 2019-08-22
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$3,500
+10,000 vol
$0.35 each
1,206,555
Filed 2019-08-21 17:21
Tx date 2019-08-21
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$680.00
+2,000 vol
$0.34 each
1,196,555
Filed 2019-08-21 17:20
Tx date 2019-08-21
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$8,250
+25,000 vol
$0.33 each
1,194,555
Filed 2019-08-19 10:47
Tx date 2019-08-15
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,200
+10,000 vol
$0.22 each
649,500
Filed 2019-08-14 07:31
Tx date 2019-08-13
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,000
+50,000 vol
$0.24 each
639,500
Filed 2019-07-25 14:47
Tx date 2019-07-25
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus
$60,000
+120,000 vol
$0.50 each
120,000
Filed 2019-07-25 14:45
Tx date 2018-12-27
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-07-25 14:44
Tx date 2019-07-25
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
15 - Acquisition or disposition under a prospectus
$60,000
+120,000 vol
$0.50 each
1,169,555
Filed 2019-07-25 11:29
Tx date 2019-07-25
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$3,000
+7,500 vol
$0.40 each
1,049,555
Filed 2019-07-25 11:28
Tx date 2019-07-24
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$4,950
+11,000 vol
$0.45 each
1,042,055
Filed 2019-07-25 11:27
Tx date 2019-07-24
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$460.00
+1,000 vol
$0.46 each
1,031,055
Filed 2019-06-25 06:38
Tx date 2019-06-19
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,697
+25,000 vol
$0.3079 each
589,500
Filed 2019-03-20
Tx date 2019-03-20
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
36 - Conversion or exchange
$22.00
+55 vol
$0.40 each
1,030,055
Filed 2019-03-05
Tx date 2019-03-01
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$700.00
+1,000 vol
$0.70 each
1,030,000
Filed 2019-02-22
Tx date 2019-02-22
$
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$695.00
+1,000 vol
$0.69 each
1,027,000
Filed 2019-02-22
Tx date 2019-02-20
$
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$650.00
+1,000 vol
$0.65 each
1,026,000
Filed 2019-02-22
Tx date 2019-02-22
$
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$1,440
+2,000 vol
$0.72 each
1,029,000
Filed 2019-02-20
Tx date 2019-02-15
$
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures Class A Shares ($1000) ($0,40 conversion price)
36 - Conversion or exchange
$
-$150,000 vol
$0.40 each
$0
Filed 2019-02-20
Tx date 2019-02-15
$
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures Class A Shares ($1000) ($0,40 conversion price)
36 - Conversion or exchange
$
-$150 vol
$0.40 each
Filed 2019-02-20
Tx date 2019-02-15
$
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures Class A Shares ($1000) ($0,40 conversion price)
15 - Acquisition or disposition under a prospectus
$
+$150,000 vol
$0.40 each
$150,000
Filed 2019-02-20
Tx date 2019-02-15
$
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures Class A Shares ($1000) ($0,40 conversion price)
15 - Acquisition or disposition under a prospectus
$
+$150 vol
$0.40 each
Filed 2019-02-19
Tx date 2019-02-15
$
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures Class A Shares ($1000) ($0,40 conversion price)
36 - Conversion or exchange
$
-$150 vol
$0.40 each
$0
Filed 2019-02-19
Tx date 2019-02-15
$
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures Class A Shares ($1000) ($0,40 conversion price)
15 - Acquisition or disposition under a prospectus
$
+$150 vol
$0.40 each
$150
Filed 2019-02-19
Tx date 2019-02-15
$
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
36 - Conversion or exchange
$150,000
+375,000 vol
$0.40 each
1,025,000
Filed 2019-02-19
Tx date 2018-12-27
$
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures Class A Shares ($1000) ($0,40 conversion price)
00 - Opening Balance-Initial SEDI Report
Filed 2019-02-18
Tx date 2019-02-15
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,079
+10,000 vol
$0.408 each
561,500
Filed 2019-02-18
Tx date 2019-02-15
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,119
+3,000 vol
$0.3733 each
564,500
Filed 2019-02-14
Tx date 2019-02-13
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,485
+5,000 vol
$0.297 each
523,000
Filed 2019-02-14
Tx date 2019-02-14
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,955
+28,500 vol
$0.3493 each
551,500
Filed 2019-01-06
Tx date 2018-12-27
$
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
975,000
Filed 2019-01-05
Tx date 2018-12-27
$
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
650,000
Filed 2018-12-27
Tx date 2018-12-19
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$840.00
+3,000 vol
$0.28 each
517,000
Filed 2018-12-27
Tx date 2018-12-21
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$290.00
+1,000 vol
$0.29 each
518,000
Filed 2018-12-27
Tx date 2018-12-19
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$11,100
+37,000 vol
$0.30 each
514,000
Filed 2018-12-19
Tx date 2018-12-14
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,640
+11,000 vol
$0.24 each
471,000
Filed 2018-12-19
Tx date 2018-12-17
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,080
+4,000 vol
$0.27 each
475,000
Filed 2018-12-19
Tx date 2018-12-18
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$560.00
+2,000 vol
$0.28 each
477,000
Filed 2018-12-19
Tx date 2018-12-14
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,360
+14,000 vol
$0.24 each
460,000
Filed 2018-12-11
Tx date 2018-12-06
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,895
+50,000 vol
$0.2179 each
445,000
Filed 2018-12-11
Tx date 2018-12-06
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,270
+25,000 vol
$0.2108 each
395,000
Filed 2018-12-11
Tx date 2018-12-06
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$280.00
+1,000 vol
$0.28 each
446,000
Filed 2018-09-28
Tx date 2018-09-18
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
370,000
Filed 2018-09-28
Tx date 2018-09-18
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
465,000
Filed 2018-03-26
Tx date 2018-03-23
$ASP
Acerus Pharmaceuticals Corporation
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+75,000 vol
1,075,000
Filed 2018-03-26
Tx date 2018-03-23
$ASP
Acerus Pharmaceuticals Corporation
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
1,175,000
Filed 2017-12-27
Tx date 2017-12-27
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,324
+50,000 vol
$0.2865 each
3,002,100
Filed 2017-12-27
Tx date 2017-12-27
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,339
+27,900 vol
$0.2989 each
3,030,000
Filed 2017-11-20
Tx date 2017-11-17
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$918.00
+5,100 vol
$0.18 each
2,952,100
Filed 2017-11-20
Tx date 2017-11-15
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$300.00
+2,000 vol
$0.15 each
2,947,000
Filed 2017-11-13
Tx date 2017-11-09
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$60,000
+500,000 vol
$0.12 each
800,000
Filed 2017-11-13
Tx date 2017-11-09
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$62,500
+500,000 vol
$0.125 each
2,695,000
Filed 2017-11-13
Tx date 2017-11-09
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,620
+13,500 vol
$0.12 each
2,708,500
Filed 2017-11-13
Tx date 2017-11-10
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$18,135
+139,500 vol
$0.13 each
2,848,000
Filed 2017-11-13
Tx date 2017-11-09
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$24,000
+200,000 vol
$0.12 each
1,000,000
Filed 2017-11-13
Tx date 2017-11-10
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$13,095
+97,000 vol
$0.135 each
2,945,000
Filed 2017-03-13
Tx date 2017-03-10
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Mainville, Luc
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
300,000
Filed 2016-12-08
Tx date 2016-12-06
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Mainville, Luc
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$11,875
+95,000 vol
$0.125 each
2,195,000
Filed 2016-11-14
Tx date 2016-11-14
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Mainville, Luc
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$13,000
+100,000 vol
$0.13 each
2,100,000
Filed 2016-08-17
Tx date 2016-08-16
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Mainville, Luc
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$90,000
+1,000,000 vol
$0.09 each
2,000,000
Filed 2016-08-12
Tx date 2016-08-11
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Mainville, Luc
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
100,000
Filed 2016-08-12
Tx date 2016-07-21
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Mainville, Luc
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-07-27
Tx date 2016-07-21
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Mainville, Luc
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
1,000,000